Vancomycin-resistant enterocci-colonized patients located in critical areas of four hospitals in Rosario City, Argentina;Enterococos vancomicina resistentes: Colonización en pacientes hospitalizados, en Rosario, Argentina

Acta Bioquimica Clinica Latinoamericana

Volumn 40, Issue 4, 2006, Pages 499-502

  Ponessa, Adriana ^a   Gambandé, Telma ^a   All, Laura ^a   De Arroyabe, Gabriel Fernández ^a   Ferrari, Mariela ^a   Dlúgovitzky, Diana ^a   Notario, Rodolfo ^a,b  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b NONE   (Argentina)

Author keywords

Colonization; Enterococcus; Enterococcus faecium; Glycopeptide; Vancomycin resistant enterococci

Indexed keywords

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM;

EID: 34547823502     PISSN: 03252957     EISSN: 03252957     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Notario R, Borda N, Gambandé T, Sutich E. Bacteriemias en dos hospitales de Rosario, Argentina. Rev Argent Microbiol 2003; 35: 167-70.
2. Murray BE. Vancomycin-resistant enterococci. Am J Med 1997; 102: 284-93.
3. Notario R, Careno E, Borda N, Gambandé T. Resistencia a los aminoglucósidos, vancomicina y actividad β-lactamasa de especies de Enterococcus. Rev Argent Infect 1993; 8: 23-7.
4. All L, Vera Blanc M, Mocarbel N, Limansky A, Viale AM, Notario R. Brote de infección por Enterococcus faecium resistentes a glicopéptidos en un hospital de Rosario, Argentina. Rev Fac Cs Méd UNCórdoba 2003; 60: 55-9.
5. Lopreto C, Viegas C, Padlog R, Sorgentini M, Bardi C, Silvestre C, et al. Detección de Enterococcus faecium resistentes a vancomicina: experiencia de 2 años en un hospital de alta complejidad. Rev Argent Microbiol 2002; 34: 222-5.
6. Daikos GL, Triantafyllopoulou P, Syriopoulou V, Bakatzouni-Pieridou D, Kontou M, Theodoulou M, et al. First cluster of vancomycin-resistant Enterococcus faecalis isolates in Cyprus. Clin Microbiol Infect 2005; 11: 232-4.
7. Depardieu F, Bonora M, Reynolds P, Courvalin P. The glycopeptide resistance operon from Enterococcus faecalis revisited. Mol Microbiol 2003; 50: 931-48.
8. Gotteberg A, Nierop W, Duse A, Kassel M, McCarthy K, Brink A, et al. Epidemiology of glycopeptide-resistant enterococci colonizing high-risk patients in hospitals in Johannesburg, Republic of South Africa. J Clin Microbiol 2000; 2: 905-9.
9. Duckro A, Blom D, Lyle E, Weinste, R, Hayden M. Transfer of vancomycin-resistant enterococci via health care worker hands. Arch Intern Med 2005; 165: 302-7.
10. Martins Teixeira M, Facklam R. Enterococcus. En: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH editors. Manual of Clinical Microbiology. 8th ed. Washington DC; ASM Press; 2003. p. 422-33.
11. CLSI Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. M100-S15. Vol 25 No1. Wayne, Pa, USA, 2005.
12. Carmeli Y, Eliopoulos GM, Samore MH. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis 2002; 8: 802-7.
13. Lautenbach E, LaRosa L, Marr A, Nachamkin I, Bilker W, Fishman N: Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis 2003; 36: 440-6.
14. Singh-naz N, Sleemi A, Pikis A, Patel K, Capos J. Vancomycin-resistant Enterococcus faecium colonization in children. J Clin Microbiol 1999; 2: 413-6.
15. Tambyah P, Marx J, Maki D. Nosocomial infection with vancomycin-dependent enterococci. Emerg Infect Dis 2004; 7: 1277-81.
16. Fridkin S, Hageman J, McDouga, L, Mohammed J, Jarvis W. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin United States, 1997-2001. Clin Infect Dis 2003; 36: 429-39.
17. Endtz H, Braak N, Belkum A, Kluytmann J, Koeleman J. Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in the Netherland. J Clin Microbiol 1997; 12: 3026-31.
18. Sorum M, Holstad G, Lillehaug A, Kruse H. Prevalence of vancomycin resistant enterococci on poultry farms established after the van of avoparcin. Avian Dis 2004; 48: 823-8.
19. Torrel E, Cars O, Olsson-Liljequist B, Hoffman B-M, Lindback J, Lars J, et al. Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant, ampicillin-resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden. J Clin Microbiol 1999; 11: 3509-3.
20. Nogueras M, Marinsalta N, Roussell M, Notario R. Importance of hand germ contamination in health-care workers as possible carriers of nosocomial infections. Rev Inst Med Trop S Paulo 2001; 43: 149-52.
21. Zeana C, Kubin C, Della-Latta P, Hammer S. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolide: case report and review of the literature. Clin Infect Dis 2001; 33: 477-82.
22. Cha R, Rybac M J. Daptomycin against multiple drug-resistant Staphylococcus and Enterococcus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations. Diagn Microbiol Infect 2003; 47: 539-46.
23. Klare I, Konstabel C, Badstubner D, Werner G, Witte W. Occurrence and spread of antibiotic resistances in Enterococcus faecium. Int J Food Microbiol 2003; 88: 269-90.
24. Bradley S, Wilson A, Allen M, Sher H, Goldstone A, Scott G. The control of hiperderendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage. J Antimicrob Chemother 1999; 43: 261-6.